SUNSHINE BIOPHARMA INC. — Income Charts
65 quarters of history · ending 2025-12-31 · SEC EDGAR
Revenue↓-10.6% -$1M
$9M
Cost of Revenue↓-14.7% -$954K
$6M
Gross Profit↓-2.1% -$64K
$3M
R&D↓-50.8% -$76K
$74K
D&A↑+50.7% +$33K
$99K
Operating Income↑+1.8% +$20K
$-1M
EBITDA↑+50.7% +$33K
$99K
Interest Expense↓-100.0% -$9K
$0
Pretax Income↑+2.5% +$129K
$5M
Tax Provision
$159K
Net Income↑+26.2% +$314K
$-884K
Gross Margin↑+3.1pts
35.3%
Operating Margin↑+1.6pts
-11.5%
Net Margin↑+4.8pts
-9.4%